Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Equity (2018 - 2025)

TransMedics has reported Return on Equity over the past 8 years, most recently at 0.25% for Q4 2025.

  • Quarterly results put Return on Equity at 0.25% for Q4 2025, up 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.25% (up 9.0% YoY), and the annual figure for FY2025 was 0.0%, down 19.0%.
  • Return on Equity for Q4 2025 was 0.25% at TransMedics, down from 0.27% in the prior quarter.
  • Over the last five years, Return on Equity for TMDX hit a ceiling of 0.27% in Q3 2025 and a floor of 0.45% in Q3 2021.
  • Median Return on Equity over the past 5 years was 0.05% (2022), compared with a mean of 0.04%.
  • Biggest five-year swings in Return on Equity: tumbled -47bps in 2021 and later skyrocketed 47bps in 2022.
  • TransMedics' Return on Equity stood at 0.0% in 2021, then plummeted by -13528bps to 0.19% in 2022, then dropped by -4bps to 0.2% in 2023, then surged by 180bps to 0.16% in 2024, then surged by 54bps to 0.25% in 2025.
  • The last three reported values for Return on Equity were 0.25% (Q4 2025), 0.27% (Q3 2025), and 0.25% (Q2 2025) per Business Quant data.